Procter & Gamble Health Ltd (PGHL) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 346859, "name": "P & G Health Ltd", "stock_name": "P & G Health Ltd", "full_name": "Procter & Gamble Health Ltd", "name_url": "stocks-analysis/p-g-health", "exchange": 1, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "5,380.50", "chg": -24.5, "chgp": "-0.45%", "dir": -1, "prev_price": "5,405.00", "mcapval": "9,002.00 Cr", "mcap": "Small Cap", "scripcode": 500126, "symbol": "PGHL", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "", "isin": "INE199A01012", "curr_date": "Jan 28", "curr_time": "", "bse_nse_vol": "18.02 k", "exc_status": "Active", "traded_date": "Jan 28, 2026", "traded_date_str": "2026 01 28", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/p-g-health-346859-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Procter & Gamble Health Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/procter-gamble-health-ltd-is-rated-sell-3794173", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ProcterGambleHe_mojoScore_3794173.png", "date": "2026-01-19 10:10:03", "description": "Procter & Gamble Health Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 January 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Why is Procter & Gamble Health Ltd falling/rising?", "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-procter-gamble-health-ltd-fallingrising-3790339", "imagepath": "", "date": "2026-01-13 01:05:41", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Performance</strong></p>\n<p>Over the past week, Procter & Gamble Health Ltd’s shares have fallen sharply by 6.8%, significantly underperforming the Sensex’s modest 1.83% decline during the same period. This downward momentum has persisted for five consecutive trading sessions, signalling sustained selling pressure. The stock also underperformed its sector by 1.87% on the day, touching an intraday low of ₹5,400, which represents a 3.09% drop from the previous close. Notably, the weighted average price indicates that a larger volume of shares traded closer to the day’s low, suggesting that sellers dominated the session.</p>\n<p>Technical indicators reinforce this bearish sentiment, with the stock currently trading below all key moving averages, including the..." }, { "title": "Procter & Gamble Health Ltd Falls 2.50%: Mixed Technicals and Valuation Weigh on Stock", "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltd-falls-250-mixed-technicals-and-valuation-weigh-on-stock-3788664", "imagepath": "", "date": "2026-01-11 09:00:07", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>5 Jan:</strong> Stock opens strong at Rs.5,837.95 (+2.16%) despite Sensex decline</p>\n <p><strong>7 Jan:</strong> Death Cross formation signals potential bearish trend</p>\n <p><strong>8 Jan:</strong> Downgrade to Sell rating amid mixed technicals and valuation concerns</p>\n <p><strong>9 Jan:</strong> Week closes at Rs.5,571.90 (-2.20%) with continued downward pressure</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.5,714.50</div></div>\n <div class=\"stat-item\"><div class=\"stat-lab..." }, { "title": "Procter & Gamble Health Ltd Downgraded to Sell Amid Mixed Technicals and Valuation Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/procter-gamble-health-ltd-downgraded-to-sell-amid-mixed-technicals-and-valuation-concerns-3785075", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ProcterGambleHe_mojoScore_3785075.png", "date": "2026-01-08 08:08:19", "description": "Procter & Gamble Health Ltd has seen its investment rating downgraded from Hold to Sell as of 7 January 2026, driven primarily by a deterioration in technical indicators and valuation metrics. Despite a solid long-term return relative to the Sensex, the company’s flat recent financial performance and expensive valuation have raised concerns among analysts, prompting a reassessment of its investment appeal." }, { "title": "Procter & Gamble Health Ltd Faces Technical Momentum Shift Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltd-faces-technical-momentum-shift-amid-mixed-indicator-signals-3785070", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ProcterGambleHe_technicaldot_3785070.png", "date": "2026-01-08 08:06:04", "description": "Procter & Gamble Health Ltd (P&G Health) has experienced a subtle shift in its technical momentum, moving from a mildly bullish to a mildly bearish trend as of early January 2026. Despite a strong long-term performance relative to the Sensex, recent technical indicators suggest caution for investors as mixed signals emerge from key momentum and trend-following tools." }, { "title": "Procter & Gamble Health Ltd Forms Death Cross, Signalling Potential Bearish Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltd-forms-death-cross-signalling-potential-bearish-trend-3784839", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ProcterGambleHe_dealthcross_3784839.png", "date": "2026-01-07 18:01:19", "description": "Procter & Gamble Health Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development suggests a potential shift towards a bearish trend, reflecting a deterioration in the stock’s medium-term momentum and raising concerns about long-term weakness in the Pharmaceuticals & Biotechnology sector player." }, { "title": "Procter & Gamble Health Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/procter-gamble-health-ltd-is-rated-hold-3773087", "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ProcterGambleHe_mojoScore_3773087.png", "date": "2025-12-29 10:10:04", "description": "Procter & Gamble Health Ltd is rated Hold by MarketsMOJO, with this rating last updated on 06 Oct 2025. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 29 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing." }, { "title": "P & G Health Sees Revision in Market Evaluation Amidst Sector Challenges", "link": "https://www.marketsmojo.com/news/stock-recommendation/p-g-health-downgraded-to-hold-by-marketsmojo-amid-valuation-concerns-3762295", "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PGHealth_mojoScore_3762295.png", "date": "2025-12-18 10:10:25", "description": "P & G Health Ltd has experienced a revision in its market evaluation, reflecting shifts in key analytical parameters that influence investor perception. This adjustment comes amid a backdrop of mixed financial trends and valuation considerations within the Pharmaceuticals & Biotechnology sector." }, { "title": "P & G Health Sees Revision in Market Evaluation Amidst Mixed Financial Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/p-g-health-downgraded-to-hold-by-marketsmojo-amid-valuation-concerns-3733197", "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PGHealth_mojoScore_3733197.png", "date": "2025-11-27 10:05:56", "description": "P & G Health Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting a nuanced shift in its financial and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, providing investors with a clearer understanding of its current standing." } ], "total": 132, "sid": "346859", "stock_news_url": "https://www.marketsmojo.com/news/procter-gamble-health-346859" }, "announcements": [ { "details": "Procter & Gamble Health Limited has informed the Exchange regarding 'Updation of Company's and Investor's Helpline numbers'.", "source": "NSE", "caption": "Procter & Gamble Health Limited - Updates", "datetime": "14-Nov-2019" }, { "details": "Procter & Gamble Health Limited has informed the Exchange regarding Board meeting held on November 07, 2019.", "source": "NSE", "caption": "Procter & Gamble Health Limited - Outcome of Board Meeting", "datetime": "08-Nov-2019" }, { "details": " <table><tr><td>Procter & Gamble Health Limited has informed the Exchange that regarding Related Party Transactions for six months ended June 30, 2019. </td></tr></table>", "source": "NSE", "caption": "Related Party Transactions", "datetime": "06-Sep-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "06 Feb 2026" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Procter & Gamble Health Ltd has declared <strong>450%</strong> dividend, ex-date: 22 Aug 25", "dt": "2025-08-22", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

5 Jan: Stock opens strong at Rs.5,837.95 (+2.16%) despite Sensex decline

7 Jan: Death Cross formation signals potential bearish trend

8 Jan: Downgrade to Sell rating amid mixed technicals and valuation concerns

9 Jan: Week closes at Rs.5,571.90 (-2.20%) with continued downward pressure

Week Open

Rs.5,714.50

Read full news article

Procter & Gamble Health Ltd Downgraded to Sell Amid Mixed Technicals and Valuation Concerns

2026-01-08 08:08:19

Procter & Gamble Health Ltd has seen its investment rating downgraded from Hold to Sell as of 7 January 2026, driven primarily by a deterioration in technical indicators and valuation metrics. Despite a solid long-term return relative to the Sensex, the company’s flat recent financial performance and expensive valuation have raised concerns among analysts, prompting a reassessment of its investment appeal.

Read full news article

Procter & Gamble Health Ltd Faces Technical Momentum Shift Amid Mixed Indicator Signals

2026-01-08 08:06:04

Procter & Gamble Health Ltd (P&G Health) has experienced a subtle shift in its technical momentum, moving from a mildly bullish to a mildly bearish trend as of early January 2026. Despite a strong long-term performance relative to the Sensex, recent technical indicators suggest caution for investors as mixed signals emerge from key momentum and trend-following tools.

Read full news article

Procter & Gamble Health Ltd Forms Death Cross, Signalling Potential Bearish Trend

2026-01-07 18:01:19

Procter & Gamble Health Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development suggests a potential shift towards a bearish trend, reflecting a deterioration in the stock’s medium-term momentum and raising concerns about long-term weakness in the Pharmaceuticals & Biotechnology sector player.

Read full news article

Procter & Gamble Health Ltd is Rated Hold

2025-12-29 10:10:04

Procter & Gamble Health Ltd is rated Hold by MarketsMOJO, with this rating last updated on 06 Oct 2025. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 29 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

P & G Health Sees Revision in Market Evaluation Amidst Sector Challenges

2025-12-18 10:10:25

P & G Health Ltd has experienced a revision in its market evaluation, reflecting shifts in key analytical parameters that influence investor perception. This adjustment comes amid a backdrop of mixed financial trends and valuation considerations within the Pharmaceuticals & Biotechnology sector.

Read full news article

P & G Health Sees Revision in Market Evaluation Amidst Mixed Financial Signals

2025-11-27 10:05:56

P & G Health Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting a nuanced shift in its financial and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, providing investors with a clearer understanding of its current standing.

Read full news article